The Impact of Vitamin A Deficiency on Tuberculosis Progression
Authors:
- 29 April 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 75 (12) , 2178-2185
Abstract
Background: Although previous studies have shown that vitamin A deficiency is associated with incident tuberculosis (TB) disease, the direction of the association has not been established. We investigated the impact of vitamin A deficiency on TB disease progression. Methods: We conducted a longitudinal cohort study nested within a randomized clinical trial among HIV-infected patients in Haiti. We compared serial vitamin A levels in individuals who developed TB disease to controls matched on age, gender, follow-up time, and time to antiretroviral therapy initiation. We also evaluated histopathology, bacterial load, and immune outcomes in TB infection in a guinea pig model of dietary vitamin A deficiency. Results: Among 773 participants, 96 developed incident TB during follow-up, 62.5% (60) of whom had stored serum samples obtained 90–365 days before TB diagnosis. In age- and sex- adjusted and multivariate analyses, respectively, incident TB cases were 3.99 times (95% confidence interval [CI], 2.41 to 6.60) and 3.59 times (95% CI, 2.05 to 6.29) more likely to have been vitamin A deficient than matched controls. Vitamin A–deficient guinea pigs manifested more extensive pulmonary pathology, atypical granuloma morphology, and increased bacterial growth after experimental TB infection. Reintroduction of dietary vitamin A to deficient guinea pigs after established TB disease successfully abrogated severe disease manifestations and altered cellular immune profiles. Conclusions: Human and animal studies support the role of baseline vitamin A deficiency as a determinant of future TB disease progression.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (U01AI057786, U19AI076217, K01OD016997, R21AI144662)
- Centers of Excellence for Translational Research (U19AI109755)
- Tuberculosis Research Units Network (U19AI111224)
- National Institute on Drug Abuse (T32DA013911)
- National Institute of Mental Health (R25MH083620)
This publication has 27 references indexed in Scilit:
- Retinoic Acid as a Modulator of T Cell ImmunityNutrients, 2016
- Retinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune SystemAnnual Review of Immunology, 2016
- Trends and mortality effects of vitamin A deficiency in children in 138 low-income and middle-income countries between 1991 and 2013: a pooled analysis of population-based surveysThe Lancet Global Health, 2015
- CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001The International Journal of Tuberculosis and Lung Disease, 2015
- All-Trans Retinoic Acid–Triggered Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on NPC2The Journal of Immunology, 2014
- A consistent log-linear relationship between tuberculosis incidence and body mass indexInternational Journal of Epidemiology, 2009
- Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophagesSeminars in Immunology, 2009
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Immunopathogenesis of Pulmonary Granulomas in the Guinea Pig after Infection withMycobacterium tuberculosisInfection and Immunity, 2003
- Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infectionThe Lancet, 1993